| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 11,771.67 | 11,055.93 | 11,025.66 | 10,080.58 |
yoy growth (%) | 6.47 | 0.27 | 9.37 | -20.16 |
Raw materials | -4,467.26 | -4,182.31 | -4,207.27 | -3,474.35 |
As % of sales | 37.94 | 37.82 | 38.15 | 34.46 |
Employee costs | -1,918.16 | -1,695.86 | -1,703.22 | -1,441.64 |
As % of sales | 16.29 | 15.33 | 15.44 | 14.3 |
Other costs | -5,177.11 | -3,133.7 | -3,207.56 | -3,078.73 |
As % of sales (Other Cost) | 43.97 | 28.34 | 29.09 | 30.54 |
Operating profit | 209.14 | 2,044.06 | 1,907.61 | 2,085.86 |
OPM | 1.77 | 18.48 | 17.3 | 20.69 |
Depreciation | -514.19 | -502.83 | -518.75 | -389.81 |
Interest expense | -73.47 | -40.62 | -52.59 | -33.24 |
Other income | 216.99 | 129.09 | 475.19 | 131.12 |
Profit before tax | -161.53 | 1,629.7 | 1,811.46 | 1,793.93 |
Taxes | -27.17 | -371.08 | -324.7 | -449.27 |
Tax rate | 16.82 | -22.76 | -17.92 | -25.04 |
Minorities and other | 0 | 0 | 0 | 0 |
Adj. profit | -188.7 | 1,258.62 | 1,486.76 | 1,344.66 |
Exceptional items | 0 | 0 | -759.21 | 0 |
Net profit | -188.7 | 1,258.62 | 727.55 | 1,344.66 |
yoy growth (%) | -114.99 | 72.99 | -45.89 | -57.19 |
NPM | -1.6 | 11.38 | 6.59 | 13.33 |
As per the terms of agreement, Lupin will hold exclusive rights for commercialisation and distribution of bofanglutide in India.
Here are some of the stocks that may see significant price movement today: Lupin, Bandhan Bank, Jubilant Foodworks, etc.
Here are some of the stocks that may see significant price movement today: HCL Tech, Bharti Airtel, Amber Enterprises, etc.
The business said that its revenue from operations registered a growth of 24.20% y-o-y at ₹7,047.50 Crore.
The inspection was held between September 8 and 16. Lupin did not disclose the details of the observations but said it would respond within the required timeline.
The launch aligns with Lupin’s strategic push into injectables, biosimilars, and inhalation therapies, supported by robust R&D and manufacturing capabilities
Here are some of the stocks that may see significant price movement today: Bharti Airtel, Torrent Power, Lupin Limited, etc.
This is eligible for 180 days of generic drug exclusivity. The company will manufacture the product at its facility situated in India.
Here are some of the stocks that may see significant price movement today: Godrej Properties, SBI Cards, Hyudai India, etc.
The tablets will be made at the company’s Goa facility, a site that has previously cleared global regulatory inspections and supports Lupin’s key exports.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
